Celldex Therapeutics
CLDX
CLDX
91 hedge funds and large institutions have $477M invested in Celldex Therapeutics in 2020 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
20% more funds holding
Funds holding: 76 → 91 (+15)
3.86% more ownership
Funds ownership: 77.19% → 81.05% (+3.9%)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
91
Holding in Top 10
2
Calls
$11M
Puts
$3.97M
Top Buyers
| 1 | +$18.5M | |
| 2 | +$11.9M | |
| 3 | +$8.08M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$7.93M |
| 5 |
RI
RTW Investments
New York
|
+$7.57M |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$11.8M | |
| 3 | -$8.34M | |
| 4 |
CA
Corriente Advisors
Fort Worth,
Texas
|
-$5.98M |
| 5 |
Millennium Management
New York
|
-$5.6M |